According to MeiraGTx's latest financial reports and stock price the company's current Operating Margin is -783.09%. At the end of 2021 the company had an Operating Margin of -211.03%.
Year | Operating Margin | Change |
---|---|---|
2021 | -211.03% | -43.37% |
2020 | -372.63% | -9.53% |
2019 | -411.87% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Organovo ONVO | -591.52% | -24.46% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -129.00% | -83.53% | ๐ฌ๐ง UK |
Novavax NVAX | -149.57% | -80.90% | ๐บ๐ธ USA |
Novocure
NVCR | -37.52% | -95.21% | Jersey |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.